StockData
Latigo Biotherapeutics, Inc. logo

Latigo Biotherapeutics, Inc. (LTGO) stock

LTGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026
$13.76+1.16 (+9.21%)

Close on Nov 17, 2026Market cap $912.28MP/E –Yield 0.00%

Latigo Biotherapeutics total assets

Total assets on the balance sheet at the end of each period.

Latigo Biotherapeutics's total assets was $408.46M at Sep 30, 2026. For fiscal 2025 it was $75.52M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$75.52M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$408.46M–
Q2 FY2026Jun 30, 2026$64.76M–
Q4 FY2025Dec 31, 2025$75.52M–

More Latigo Biotherapeutics figures

See a number that looks wrong?